{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_001146211.3:c.137G>A",
                    "cDNA Change": {
                        "transcript": "NM_001146211.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "137"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "K",
                        "position": "46"
                    },
                    "Description in input context": "E46K"
                },
                {
                    "HGVS": "NM_001146211.3:c.89C>T",
                    "cDNA Change": {
                        "transcript": "NM_001146211.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "V",
                        "position": "30"
                    },
                    "Description in input context": "A30P"
                },
                {
                    "HGVS": "NM_001146211.3:c.158C>A",
                    "cDNA Change": {
                        "transcript": "NM_001146211.3",
                        "ref": "C",
                        "alt": "A",
                        "position": "158"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T"
                },
                {
                    "HGVS": "NM_001146211.3:c.89C>T/c.158C>A",
                    "cDNA Change": {
                        "transcript": "NM_001146211.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "V",
                        "position": "30"
                    },
                    "Description in input context": "A30P/A53T"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Lewy body diseases",
        "MONDO": "MONDO:0005078"
    },
    "Experiment Method": [
        {
            "Assay Method": "Thioflavin S assay",
            "Material used": {
                "Material Source": "Recombinant Peptide Technologies",
                "Material Name": "α-synuclein (αS) variants",
                "Description": "wild-type αS (WT), E46K mutant αS, A30P mutant αS, A53T mutant αS, and A30P/A53T mutant αS"
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_001146211.3:c.137G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "accelerated kinetics of secondary structure change and oligomerization",
                    "Result Description": "E46K αS accelerated the kinetics of the secondary structure change and oligomerization, whereas A30P αS decelerated them."
                },
                {
                    "Variant": "NM_001146211.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "decelerated kinetics of secondary structure change and oligomerization",
                    "Result Description": "A30P αS decelerated the kinetics of the secondary structure change and oligomerization."
                },
                {
                    "Variant": "NM_001146211.3:c.158C>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "accelerated kinetics of secondary structure change and oligomerization",
                    "Result Description": "A53T αS accelerated the kinetics of the secondary structure change and oligomerization."
                },
                {
                    "Variant": "NM_001146211.3:c.89C>T/c.158C>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "accelerated kinetics of secondary structure change and oligomerization",
                    "Result Description": "A30P/A53T αS accelerated the kinetics of the secondary structure change and oligomerization."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Circular dichroism spectroscopy",
            "Material used": {
                "Material Source": "Recombinant Peptide Technologies",
                "Material Name": "α-synuclein (αS) variants",
                "Description": "wild-type αS (WT), E46K mutant αS, A30P mutant αS, A53T mutant αS, and A30P/A53T mutant αS"
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_001146211.3:c.137G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "accelerated kinetics of secondary structure change",
                    "Result Description": "E46K αS displayed substantially accelerated kinetic, with t1/2≈0.6 d."
                },
                {
                    "Variant": "NM_001146211.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "decelerated kinetics of secondary structure change",
                    "Result Description": "A30P αS displayed substantial secondary structure changes during days 1–6, with t1/2≈1.6 d."
                },
                {
                    "Variant": "NM_001146211.3:c.158C>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "slightly accelerated kinetics of secondary structure change",
                    "Result Description": "A53T αS peptides displayed slightly accelerated kinetics, with t1/2≈1.1 d."
                },
                {
                    "Variant": "NM_001146211.3:c.89C>T/c.158C>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "slightly accelerated kinetics of secondary structure change",
                    "Result Description": "A30P/A53T αS peptides displayed slightly accelerated kinetics, with t1/2≈1.1 d."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Electron microscopy",
            "Material used": {
                "Material Source": "Recombinant Peptide Technologies",
                "Material Name": "α-synuclein (αS) variants",
                "Description": "wild-type αS (WT), E46K mutant αS, A30P mutant αS, A53T mutant αS, and A30P/A53T mutant αS"
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_001146211.3:c.137G>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "E46K αS ﬁbrils formed a uniformly long, non-branched ﬁlament structure and there were no clear differences morphologically."
                },
                {
                    "Variant": "NM_001146211.3:c.89C>T",
                    "Conclusion": "Normal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "A30P αS ﬁbrils formed a uniformly long, non-branched ﬁlament structure and there were no clear differences morphologically."
                },
                {
                    "Variant": "NM_001146211.3:c.158C>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "A53T αS ﬁbrils formed a uniformly long, non-branched ﬁlament structure and there were no clear differences morphologically."
                },
                {
                    "Variant": "NM_001146211.3:c.89C>T/c.158C>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "N.D.",
                    "Result Description": "A30P/A53T αS ﬁbrils formed a uniformly long, non-branched ﬁlament structure and there were no clear differences morphologically."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Atomic force microscopy",
            "Material used": {
                "Material Source": "Recombinant Peptide Technologies",
                "Material Name": "α-synuclein (αS) variants",
                "Description": "wild-type αS (WT), E46K mutant αS, A30P mutant αS, A53T mutant αS, and A30P/A53T mutant αS"
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_001146211.3:c.137G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "larger oligomers",
                    "Result Description": "E46K αS produced an assembly with larger oligomers than WT αS."
                },
                {
                    "Variant": "NM_001146211.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "smaller oligomers",
                    "Result Description": "A30P αS produced an assembly with smaller oligomers."
                },
                {
                    "Variant": "NM_001146211.3:c.158C>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "similar oligomer size to WT",
                    "Result Description": "A53T αS oligomers had a similar morphology with diameters of 10.79±0.82 nm."
                },
                {
                    "Variant": "NM_001146211.3:c.89C>T/c.158C>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "similar oligomer size to WT",
                    "Result Description": "A30P/A53T αS oligomers had a similar morphology with diameters of 10.98±0.97 nm."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}